Loading...

Athenex, Inc.

ATNXNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.20
$0.00(0.00%)

Athenex, Inc. ATNX Peers

See (ATNX) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
ATNX$0.20N/A2.3M-0.02-$10.45N/A
ZTS$168.62-0.99%75.1B30.27$5.57+1.11%
HLN$10.94-1.00%49.7B26.04$0.42+1.53%
TAK$15.02+0.37%47.3B65.30$0.23+3.92%
TEVA$17.53+1.95%20.1B-15.24-$1.15N/A
ITCI$131.87N/A14B-180.64-$0.73N/A
NBIX$124.52-0.38%12.3B42.21$2.95N/A
RDY$14.74+0.55%12.3B18.66$0.79+0.65%
CTLT$63.48N/A11.5B-27.84-$2.28N/A
VTRS$8.59-1.38%10.1B-2.70-$3.18+5.54%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

ATNX vs ZTS Comparison

ATNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ATNX stands at 2.3M. In comparison, ZTS has a market cap of 75.1B. Regarding current trading prices, ATNX is priced at $0.20, while ZTS trades at $168.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ATNX currently has a P/E ratio of -0.02, whereas ZTS's P/E ratio is 30.27. In terms of profitability, ATNX's ROE is +0.22%, compared to ZTS's ROE of +0.51%. Regarding short-term risk, ATNX is less volatile compared to ZTS. This indicates potentially lower risk in terms of short-term price fluctuations for ATNX.

Stock Price Comparison

Loading...

Frequently Asked Questions